Evidence map›Paper›PMID 40979378›Full record

ArticleFrontiers in drug safety and regulation2024

Cohort event monitoring of safety of COVID-19 vaccines: the Italian experience of the "ilmiovaccinoCOVID19 collaborating group".

Nicoletta Luxi, Chiara Bellitto, Francesco Ciccimarra, Emiliano Cappello, Luca L'Abbate, Marco Bonaso, Chiara Ajolfi, Paolo Baldo, Roberto Bonaiuti, Claudio Costantino and 23 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in drug safety and regulation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Nicoletta LuxiDepartment of Medicine, University of Verona, Verona, Italy.
Chiara BellittoDepartment of Diagnostics and Public Health, University of Verona, Verona, Italy.
Francesco CiccimarraDepartment of Diagnostics and Public Health, University of Verona, Verona, Italy.
Emiliano CappelloUnit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Luca L'AbbateDepartment of Diagnostics and Public Health, University of Verona, Verona, Italy.
Marco BonasoUnit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Chiara AjolfiModena Local Health Unit, Modena, Italy.
Paolo BaldoHospital Pharmacy Unit, Centro di Riferimento Oncologico di Aviano, National Cancer Institute, IRCCS, Aviano, Italy.
Roberto BonaiutiPeaRL-Perinatal Research Laboratory, Department of Neurosciences, Psychology, Drug Research and Child Health, CiaoLapo Foundation, University of Florence, Florence, Italy.
Claudio CostantinoDepartment of Health Promotion, Maternal and Infant Care, Internal Medicine and Excellence Specialties "G. D'Alessandro" - University of Palermo, Palermo, Italy.
Giovambattista De SarroDepartment of Health Sciences, School of Medicine and Surgery, Magna Graecia University of Catanzaro, Catanzaro, Italy.
Cristina Di MauroCaserta Local Health Unit, Caserta, Italy.
Giuseppina FavaReggio Calabria Local Health Unit, Reggio Calabria, Italy.
Marina FerriAutonomous Province of Trento, Pharmacovigilance Centre, Trento, Italy.
Alberto FirenzeStruttura Commissariale dell'Azienda Ospedaliera Papardo, Messina, Italy.
Fabiana FurciProvincial Healthcare Unit, Section of Allergy, Vibo Valentia, Italy.
Luca GallelliDepartment of Health Sciences, School of Medicine and Surgery, Magna Graecia University of Catanzaro, Catanzaro, Italy.
Luca LeonardiAutonomous Province of Trento, Pharmacovigilance Centre, Trento, Italy.
Giovanna NegriParma Local Health Unit, Parma, Italy.
Fabio PieracciniRomagna Local Health Unit, Romagna, Italy.
Elisabetta PoluzziPharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Chiara SacripantiBologna Local Health Unit, Bologna, Italy.
Elisa SangiorgiArea Governo del Farmaco e dei Dispositivi Medici, Regione Emilia Romagna, Bologna, Italy.
Ester SapigniEmilia-Romagna Pharmacovigilance Regional Centre, Bologna, Italy.
Ilenia SenesiAbruzzo Region, Pharmacovigilance Regional Centre, Bologna, Italy.
Roberto TessariIRCCS Ospedale Sacro Cuore Don Calabria-Hospital Pharmacy, Negrar di Valpolicella, Italy.
Luigia TrabaceDepartment of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
Alfredo VannacciPeaRL-Perinatal Research Laboratory, Department of Neurosciences, Psychology, Drug Research and Child Health, CiaoLapo Foundation, University of Florence, Florence, Italy.
Francesca VenturiniPharmacy Department, University Hospital of Padua, Padua, Italy.
Francesco VitaleDepartment of Health Promotion, Maternal and Infant Care, Internal Medicine and Excellence Specialties "G. D'Alessandro" - University of Palermo, Palermo, Italy.
Donatella ZoddaMessina Local Health Unit, Messina, Italy.
Marco TuccoriUnit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Gianluca TrifiròDepartment of Diagnostics and Public Health, University of Verona, Verona, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

active surveillanceCOVID-19passive surveillancespecial cohortsvaccine safety

Identifiers

PMID40979378
PMCPMC12445166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.